Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

SUGI PHARMACY to report quarterly results on April 9; analysts see significantly lower EPS, revenue rises

SUGI PHARMACY will release figures for the quarter ended February 28, 2026 on April 9, 2026. Three analysts expect an average EPS of 17.45 JPY (prior year: 36.65 JPY). Six analysts forecast revenue of 258.54 billion JPY, up 6.22% versus the same quarter last year. For the just-ended fiscal year, seven analysts' average estimates are EPS of 248.14 JPY (prior year: 141.96 JPY) and revenue of 1,008.86 billion JPY (prior year: 878.02 billion JPY). » Mere på finanzen.net
SUGI PHARMACY to release quarterly results on January 8, analysts see strong profit and revenue growth

SUGI PHARMACY will publish the quarter-end balance sheet for the period to November 30, 2025 on January 8. Three analysts expect EPS of JPY 41.86 per share (+26.31% vs. the prior year) and six analysts forecast revenue of JPY 247.85 billion (+12.25% vs. the prior year). For the current fiscal year, consensus estimates are JPY 246.97 earnings per share and annual revenue of JPY 1,009.77 billion. » Mere på finanzen.net
SUGI PHARMACY expects higher quarterly profit and revenue

SUGI PHARMACY is expected to announce results for the most recent quarter on 08.01.2026. Three analysts forecast an average EPS of 41.86 JPY versus 33.14 JPY a year earlier, with average revenue of 246.66 billion JPY versus 220.81 billion JPY. For the current fiscal year, the average estimates from ten analysts are earnings per share of 247.30 JPY (prior year 141.96 JPY) and revenue of 1,009.63 billion JPY (prior year 878.02 billion JPY). » Mere på finanzen.net

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2025 har Sugi allerede udloddet 0,20 € i udbytte. Den seneste udlodning fandt sted i november 2025.

Virksomhedstal

I det seneste kvartal havde Sugi en omsætning på 1,46 mia. € og et nettoresultat på 37,17 mio. €

(EUR)	maj 2026	YoY
Omsætning	1,46 mia.	3,07 %
Bruttofortjeneste	448,88 mio.	2,94 %
Nettoresultat	37,17 mio.	71,37 %
EBITDA	94,71 mio.	1,23 %

Fundamentale data

Nøgletal	Værdi
Markedsværdi	2,63 mia. €
Antal aktier	372,11 mio.
Højeste/laveste i 52 uger	11,15 € - 7,05 €
Udbytteafkast	1,16 %
Udbytte TTM	0,0847 €
Beta	0,28
P/E (PE Ratio)	14,92
PEG (PEG Ratio)	-0,60
K/I (PB Ratio)	1,56
P/S (PS Ratio)	0,45

Virksomhedsprofil

Sugi Holdings Co.,Ltd. betreibt Drogerien in Japan. Darüber hinaus bietet das Unternehmen Krankenpflegedienste und häusliche Pflegedienstleistungen an. Zum 1. Juni 2019 betrieb das Unternehmen 1.190 Filialen. Sugi Holdings Co.,Ltd. wurde 1976 gegründet und hat seinen Hauptsitz in Obu, Japan.